71.16USD+1.79%Mkt Cap: 2.74B USDP/E: —Last update: 2026-06-01
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hemato…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap2.74B USD
Enterprise Value1.96B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-212.18M USD
Revenue/Share—
Last Price71.16 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees154
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.27
PEG—
EV/EBITDA-7.41
EV/Revenue—
P/S—
P/B3.86
EPS (TTM)-6.64
EPS (Forward)-7.50
52W Range
40.0052% of range99.50
52W High99.50 USD
52W Low40.00 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-28.68%
ROA-26.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-180.39M USD
CapEx (TTM)933.00K USD
FCF Margin—
FCF Yield-4.43%
Net Debt-699.10M USD
Net Debt/EBITDA2.64
Balance Sheet
Debt/Equity0.04
Current Ratio24.00
Quick Ratio23.45
Book Value/Sh18.03 USD
Cash/Share19.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateDec 30, 2022
Analyst Consensus
Rating—
Target (Mean)101.09 USD
Target Range79.00 USD – 128.00 USD
# Analysts11
Ownership
Shares Out.38.20M
Float32.75M
Insiders7.78%
Institutions113.59%
Short Interest
Short Ratio12.8d
Short % Float17.32%
Short % Out.14.84%
Shares Short5.67M
Short (prev mo.)5.24M
Technical
SMA 5066.49 (+7.0%)
SMA 20072.46 (-1.8%)
Beta2.14
S&P 52W Chg27.94%
Avg Vol (30d)412.49K
Avg Vol (10d)476.28K
Technical Indicators
RSI (14)56.5
MACD0.4893
MACD Signal0.2526
MACD Hist.+0.2367
BB Upper71.20 USD
BB Middle68.06 USD
BB Lower64.92 USD
BB Width9.23%
ATR (14)2.912 USD
Vol Ratio (20d)0.43x